Skip to main content
. 2023 Feb 24;28:100595. doi: 10.1016/j.lanepe.2023.100595

Fig. 2.

Fig. 2

Symptoms affecting everyday life. Percentages of participants reporting at least one persisting symptom in the respective domain rated as at least 3/5 (a moderate degree of impact on everyday life).♦Significant improvement at 24 months (p < 0.001) according to the paired Wilcoxon signed-rank test.